High dose erythropoietin may not be efficacious for neuroprotection in extremely preterm infants
1. In this randomized controlled trial involving extremely preterm infants, high dose erythropoietin did not reduce the risk of death ...
1. In this randomized controlled trial involving extremely preterm infants, high dose erythropoietin did not reduce the risk of death ...
1. A multicenter randomized control trial concluded that n-3 polyunsaturated fatty acid supplementation in pregnancy did not change the risk ...
1. A multicenter randomized control trial concluded that n-3 polyunsaturated fatty acid supplementation in pregnancy did not change the risk ...
Gender differences in Twitter use and influence among health policy and health services researchers 1. Women’s voices on common social ...
Preeclampsia is associated with increased morbidity and mortality for both mother and infant. In addition to maternal and fetal assessment, ...
Preterm birth is the leading cause of infant mortality and neonatal morbidity. Maternal obesity is associated with an increased risk ...
Efficacy of prehospital criteria in identifying trauma patients susceptible to undertriage While the early recognition of severe traumatic injury is ...
Fetal nephrogenesis is most significant in the third trimester of pregnancy, and is interrupted by preterm birth before 37 weeks ...
Preterm birth remains a leading cause of lifelong neurodevelopmental disability. While the effect of brain injury on neurodevelopmental disability has ...
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.